Ronald Valdez

Ronald Valdez

Auto-generated profile, based on publicly available information

Ronald Valdez

Centro de Medicina Avanzada CEDIMAT. Santo Domingo, República Dominicana

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2026 in Ciencia y Salud
Verified
Journal Article
Open access
PDF file
EDEliana Diná-Batlle
Eliana Diná-Batlle
ECErwin Campos
Erwin Campos
RVRonald Valdez
Ronald Valdez
ACAdhanellys Cáceres
Adhanellys Cáceres
SRSilvano Rodríguez
Silvano Rodríguez
GÁGuillermo Álvarez
Guillermo Álvarez
Introduction: Hyperkalemia is a potentially fatal electrolyte disorder that is particularly common in patients with chronic kidney disease (CKD), diabetes mellitus, and heart failure, and its management varies widely in clinical practice in the Dominican Republic. The consequences of inadequate management include serious cardiovascular events, hospitalizations, and discontinuation of renoprotective therapies. Objective: To develop a national consensus algorithm for the standardized management and treatment of acute and chronic hyperkalemia in adults, tailored to clinical practice and therapeutic availability in the Dominican Republic. Methodology: A structured methodology based on the GRADE approach was applied, including a critical review of international guidelines and clinical trials (2020–2024), prioritizing evidence applicable to Latin America. Recommendations were classified according to their strength and quality, incorporating the expert judgment of Dominican nephrologists. The algorithm addresses the definition, diagnosis, triage, stepwise treatment, chronic management strategies, and implementation measures at different levels of care. Conclusions: The algorithm proposes a stepwise approach to acute hyperkalemia (≥6.5 mEq/L or abnormal ECG) that includes cardiac stabilization, potassium redistribution, effective elimination, and continuous monitoring. In chronic settings, dietary education, regular monitoring, and the rational use of diuretics, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and resins are recommended. This consensus serves as a practical tool to standardize the management of hyperkalemia and reduce its complications in the country.